Skip to main content
Top
Published in: Heart and Vessels 5/2011

01-09-2011 | Original Article

Clinical analysis of the risk factors of slow coronary flow

Authors: Shuang Xia, Song-Bai Deng, Yang Wang, Jun Xiao, Jian-Lin Du, Yu Zhang, Xi-Chun Wang, Ye-Qing Li, Rui Zhao, Li He, Yu-Luan Xiang, Qiang She

Published in: Heart and Vessels | Issue 5/2011

Login to get access

Abstract

Slow coronary flow (SCF) phenomenon is a coronary microvascular disorder characterized by the delayed passage of contrast in the absence of obstructive epicardial coronary disease, and is an important clinical entity because it may be the cause of precordial pain when the body is at rest and/or during exercise. Although clinical and pathological features of SCF have been previously described, its etiopathogenesis remains unclear. The present study aims to investigate the risk factors of slow coronary flow, in order to provide the foundation for further exploration of potential mechanisms of SCF. A total of 47 consecutive patients with documented slow coronary flow, and 33 patients with normal coronary flow—as defined by TIMI frame count (TFC)—were recruited for this study. Clinical information was collected, and biochemical indicators including high-sensitivity C-reactive protein (hs-CRP), and a marker of systemic inflammation were detected. Logistic regression analysis was performed for statistical analysis. SCF patients had a higher level of serum uric acid (323.2 ± 79.3 vs. 282.8 ± 82.4 μmol/l, p = 0.03), 2-h postprandial blood glucose (8.6 ± 2.7 vs. 7.5 ± 1.8 mmol/l, p = 0.04), platelet count (165.9 ± 51.6 × 103 vs. 127.0 ± 32.0 × 103 cells/μl, p = 0.0003) and hs-CRP (3.4 ± 0.8 vs. 2.0 ± 0.9 mg/l, p < 0.0001) than those of patients in the control group. No marked differences in other variables were observed between the two groups. Logistic regression showed serum uric acid level (χ2 = 3.84, β = 0.007, p = 0.049), 2-h postprandial blood glucose (χ2 = 5.02, β = 0.277, p = 0.025) and blood platelet count (χ2 = 12.16, β = 0.026, p = 0.001) were independent predictors of SCF. When hs-CRP was included in the multivariate model, hs-CRP (χ2 = 21.19, β = 1.90, p < 0.0001) was the only independent predictor of SCF. These findings suggested that an elevation of serum uric acid level, 2-h postprandial blood glucose, and blood platelet count might be the causes of SCF, and inflammation was likely to be implicated in the causal pathway leading to SCF.
Literature
1.
go back to reference Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E (1972) Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding. Am Heart J 84:66–71PubMedCrossRef Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E (1972) Angina pectoris and slow flow velocity of dye in coronary arteries: a new angiographic finding. Am Heart J 84:66–71PubMedCrossRef
2.
go back to reference Beltrame JF, Limaye SB, Horowitz JD (2002) The coronary slow flow phenomenon—a new coronary microvascular disorder. Cardiology 97:197–202PubMedCrossRef Beltrame JF, Limaye SB, Horowitz JD (2002) The coronary slow flow phenomenon—a new coronary microvascular disorder. Cardiology 97:197–202PubMedCrossRef
3.
go back to reference Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, Yetkin E, Tandogan I, Kosar F, Ermis N, Yologlu S, Bariskaner E, Cehreli S (2003) Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 14:155–161PubMedCrossRef Sezgin AT, Sigirci A, Barutcu I, Topal E, Sezgin N, Ozdemir R, Yetkin E, Tandogan I, Kosar F, Ermis N, Yologlu S, Bariskaner E, Cehreli S (2003) Vascular endothelial function in patients with slow coronary flow. Coron Artery Dis 14:155–161PubMedCrossRef
4.
go back to reference Mosseri M, Yarom R, Gotsman, Hasin Y (1986) Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 74:964–972PubMedCrossRef Mosseri M, Yarom R, Gotsman, Hasin Y (1986) Histologic evidence for small vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 74:964–972PubMedCrossRef
5.
go back to reference Pekdemir H, Cin VG, Ciçek D, Camsari A, Akkus N, Döven O, Parmaksiz HT (2004) Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 59:127–133PubMedCrossRef Pekdemir H, Cin VG, Ciçek D, Camsari A, Akkus N, Döven O, Parmaksiz HT (2004) Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 59:127–133PubMedCrossRef
6.
go back to reference Camsari A, Ozcan T, Ozer C, Akcay B (2008) Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis 200:310–314PubMedCrossRef Camsari A, Ozcan T, Ozer C, Akcay B (2008) Carotid artery intima-media thickness correlates with intravascular ultrasound parameters in patients with slow coronary flow. Atherosclerosis 200:310–314PubMedCrossRef
7.
go back to reference Selcuk H, Selcuk MT, Temizhan A, Maden O, Saydam GS, Ulupinar H, Dogan M, Aydin C, Topcu DI, Sasmaz A (2009) Decreased plasma concentrations of adiponectin in patients with slow coronary flow. Heart Vessels 24:1–7PubMedCrossRef Selcuk H, Selcuk MT, Temizhan A, Maden O, Saydam GS, Ulupinar H, Dogan M, Aydin C, Topcu DI, Sasmaz A (2009) Decreased plasma concentrations of adiponectin in patients with slow coronary flow. Heart Vessels 24:1–7PubMedCrossRef
8.
go back to reference Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, Dell’Italia LJ, Scibilia G, Motta P, Campa PP (1996) Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 37:375–381PubMedCrossRef Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, Dell’Italia LJ, Scibilia G, Motta P, Campa PP (1996) Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 37:375–381PubMedCrossRef
9.
go back to reference Amasyali B, Turhan H, Kose S, Celik T, Iyisoy A, Kursaklioglu H, Isik E (2006) Aborted sudden cardiac death in a 20-year-old man with slow coronary flow. Int J Cardiol 109:427–429PubMedCrossRef Amasyali B, Turhan H, Kose S, Celik T, Iyisoy A, Kursaklioglu H, Isik E (2006) Aborted sudden cardiac death in a 20-year-old man with slow coronary flow. Int J Cardiol 109:427–429PubMedCrossRef
10.
go back to reference Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E (2008) Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol 31:352–355PubMedCrossRef Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E (2008) Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol 31:352–355PubMedCrossRef
11.
go back to reference Cakmak M, Tanriverdi H, Cakmak N, Evrengul H, Cetemen S, Kuru O (2008) Simvastatin may improve myocardial perfusion abnormality in slow coronary flow. Cardiology 110:39–44PubMedCrossRef Cakmak M, Tanriverdi H, Cakmak N, Evrengul H, Cetemen S, Kuru O (2008) Simvastatin may improve myocardial perfusion abnormality in slow coronary flow. Cardiology 110:39–44PubMedCrossRef
12.
go back to reference Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879–888PubMed Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E (1996) TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93:879–888PubMed
13.
go back to reference Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546–1551PubMedCrossRef Niskanen LK, Laaksonen DE, Nyyssönen K, Alfthan G, Lakka HM, Lakka TA, Salonen JT (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546–1551PubMedCrossRef
14.
go back to reference Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ (2008) Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 58:623–630PubMedCrossRef Ioachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ (2008) Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 58:623–630PubMedCrossRef
15.
go back to reference Yildiz A, Yilmaz R, Demirbag R, Gur M, Bas MM, Erel O (2007) Association of serum uric acid level and coronary blood flow. Coron Artery Dis 18:607–613PubMedCrossRef Yildiz A, Yilmaz R, Demirbag R, Gur M, Bas MM, Erel O (2007) Association of serum uric acid level and coronary blood flow. Coron Artery Dis 18:607–613PubMedCrossRef
16.
go back to reference Maxwell AJ, Bruinsma KA (2001) Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 38:1850–1858PubMedCrossRef Maxwell AJ, Bruinsma KA (2001) Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol 38:1850–1858PubMedCrossRef
17.
go back to reference Sezgin N, Barutcu I, Sezgin AT, Gullu H, Turkmen M, Esen AM, Karakaya O (2005) Plasma nitric oxide level and its role in slow coronary flow phenomenon. Int Heart J 46:373–382PubMedCrossRef Sezgin N, Barutcu I, Sezgin AT, Gullu H, Turkmen M, Esen AM, Karakaya O (2005) Plasma nitric oxide level and its role in slow coronary flow phenomenon. Int Heart J 46:373–382PubMedCrossRef
18.
go back to reference Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G (1999) When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 340:143–152PubMedCrossRef Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G (1999) When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 340:143–152PubMedCrossRef
19.
go back to reference Enli Y, Turk M, Akbay R, Evrengul H, Tanriverdi H, Kuru O, Seleci D, Kaftan A, Ozer O, Enli H (2008) Oxidative stress parameters in patients with slow coronary flow. Adv Ther 25:37–44PubMedCrossRef Enli Y, Turk M, Akbay R, Evrengul H, Tanriverdi H, Kuru O, Seleci D, Kaftan A, Ozer O, Enli H (2008) Oxidative stress parameters in patients with slow coronary flow. Adv Ther 25:37–44PubMedCrossRef
20.
go back to reference Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH (2009) Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels 24:371–375PubMedCrossRef Tsai WC, Huang YY, Lin CC, Li WT, Lee CH, Chen JY, Chen JH (2009) Uric acid is an independent predictor of arterial stiffness in hypertensive patients. Heart Vessels 24:371–375PubMedCrossRef
21.
go back to reference Patetsios P, Song M, Shutze WP, Pappas C, Rodino W, Ramirez JA, Panetta TF (2001) Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol 88:188–191PubMedCrossRef Patetsios P, Song M, Shutze WP, Pappas C, Rodino W, Ramirez JA, Panetta TF (2001) Identification of uric acid and xanthine oxidase in atherosclerotic plaque. Am J Cardiol 88:188–191PubMedCrossRef
22.
go back to reference Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:991–997 Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, Kang DH, Gordon KL, Watanabe S, Nakagawa T, Lan HY, Johnson RJ (2002) Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 282:991–997
23.
go back to reference DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405 DECODE Study Group (2001) Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397–405
24.
go back to reference Sorkin JD, Muller DC, Fleg JL, Andres R (2005) The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28:2626–2632PubMedCrossRef Sorkin JD, Muller DC, Fleg JL, Andres R (2005) The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28:2626–2632PubMedCrossRef
25.
go back to reference Binak E, Gunduz H, Sahin M, Kurtoglu N, Dindar I (2006) The relation between impaired glucose tolerance and slow coronary flow. Int J Cardiol 111:142–146PubMedCrossRef Binak E, Gunduz H, Sahin M, Kurtoglu N, Dindar I (2006) The relation between impaired glucose tolerance and slow coronary flow. Int J Cardiol 111:142–146PubMedCrossRef
26.
go back to reference Golay A, Guitard C, Hoyer M, O Logan J, Brunel PC (2004) Assessment of postprandial glucose: relationship between a standardised continental breakfast and the oral glucose tolerance test. Br J Diabetes Vas Dis 4:321–324 Golay A, Guitard C, Hoyer M, O Logan J, Brunel PC (2004) Assessment of postprandial glucose: relationship between a standardised continental breakfast and the oral glucose tolerance test. Br J Diabetes Vas Dis 4:321–324
27.
go back to reference Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146–154PubMedCrossRef Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146–154PubMedCrossRef
28.
go back to reference Vehkavaara S, Seppala-Lindroos A, Westerbacka J, Groop PH, Yki-Jarvinen H (1999) In vivo endothelial dysfunction characterizes patients with impaired glucose tolerance. Diabetes Care 22:2055–2060PubMedCrossRef Vehkavaara S, Seppala-Lindroos A, Westerbacka J, Groop PH, Yki-Jarvinen H (1999) In vivo endothelial dysfunction characterizes patients with impaired glucose tolerance. Diabetes Care 22:2055–2060PubMedCrossRef
29.
go back to reference Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T (1999) Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness innon-diabetic individuals. Atherosclerosis 144:229–235PubMedCrossRef Hanefeld M, Koehler C, Schaper F, Fuecker K, Henkel E, Temelkova-Kurktschiev T (1999) Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness innon-diabetic individuals. Atherosclerosis 144:229–235PubMedCrossRef
30.
go back to reference Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9–15PubMedCrossRef Fujii N, Tsuchihashi K, Sasao H, Eguchi M, Miurakami H, Hase M, Higashiura K, Yuda S, Hashimoto A, Miura T, Ura N, Shimamoto K (2008) Insulin resistance functionally limits endothelium-dependent coronary vasodilation in nondiabetic patients. Heart Vessels 23:9–15PubMedCrossRef
31.
go back to reference Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84:613–617PubMed Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84:613–617PubMed
32.
go back to reference Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, Gibson CM, TIMI Study Group (2006) Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol 98:1–5PubMedCrossRef Ly HQ, Kirtane AJ, Murphy SA, Buros J, Cannon CP, Braunwald E, Gibson CM, TIMI Study Group (2006) Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol 98:1–5PubMedCrossRef
33.
go back to reference Gökçe M, Kaplan S, Tekelioğlu Y, Erdoğan T, Küçükosmanoğlu M (2005) Platelet function disorder in patients with coronary slow flow. Clin Cardiol 28:145–148PubMedCrossRef Gökçe M, Kaplan S, Tekelioğlu Y, Erdoğan T, Küçükosmanoğlu M (2005) Platelet function disorder in patients with coronary slow flow. Clin Cardiol 28:145–148PubMedCrossRef
34.
go back to reference Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y (2009) Increased mean platelet volume in patients with slow coronary flow. Platelets 20:23–28PubMedCrossRef Sen N, Basar N, Maden O, Ozcan F, Ozlu MF, Gungor O, Cagli K, Erbay AR, Balbay Y (2009) Increased mean platelet volume in patients with slow coronary flow. Platelets 20:23–28PubMedCrossRef
35.
go back to reference Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, Okumura N, Nakahata T (1991) Interleukin 6 supports human megakaryocytes proliferation and differentiation in vitro. Blood 78:1969–1974PubMed Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, Okumura N, Nakahata T (1991) Interleukin 6 supports human megakaryocytes proliferation and differentiation in vitro. Blood 78:1969–1974PubMed
36.
go back to reference Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T (1990) In vivo effects of recombinant human interleukin 6 in primates: stimulated production of platelets. Blood 75:1602–1605PubMed Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T (1990) In vivo effects of recombinant human interleukin 6 in primates: stimulated production of platelets. Blood 75:1602–1605PubMed
37.
go back to reference Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, Zhang CY, Li J (2007) Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 385:43–47PubMedCrossRef Li JJ, Qin XW, Li ZC, Zeng HS, Gao Z, Xu B, Zhang CY, Li J (2007) Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow. Clin Chim Acta 385:43–47PubMedCrossRef
38.
go back to reference Holme S, Murphy S (1981) Influence of platelet count and size on aggregation studies. J Lab Clin Med 97:623–630PubMed Holme S, Murphy S (1981) Influence of platelet count and size on aggregation studies. J Lab Clin Med 97:623–630PubMed
39.
go back to reference Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, Yamauchi I, Okumura T, Nin K, Tokuyama K, Yamadori N, Ogura M, Kuroe A, Nakai Y (2003) Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 52:1246–1249PubMedCrossRef Taniguchi A, Fukushima M, Seino Y, Sakai M, Yoshii S, Nagasaka S, Yamauchi I, Okumura T, Nin K, Tokuyama K, Yamadori N, Ogura M, Kuroe A, Nakai Y (2003) Platelet count is independently associated with insulin resistance in non-obese Japanese type 2 diabetic patients. Metabolism 52:1246–1249PubMedCrossRef
40.
go back to reference Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17:802–807PubMedCrossRef Brown AS, Hong Y, de Belder A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin JF, Erusalimsky JD (1997) Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 17:802–807PubMedCrossRef
41.
go back to reference Tannous M, Rabini RA, Vignini A, Moretti N, Fumelli P, Zielinski B, Mazzanti L, Mutus B (1999) Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 42:539–544PubMedCrossRef Tannous M, Rabini RA, Vignini A, Moretti N, Fumelli P, Zielinski B, Mazzanti L, Mutus B (1999) Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 42:539–544PubMedCrossRef
42.
go back to reference Mangieri E, Tanzilli G, De Vincentis G, Barillà F, Remediani S, Acconcia MC, Comito C, Gaudio C, Scopinaro F, Puddu PE, Critelli G (2006) Slow coronary flow and stress myocardial perfusion imaging. Different patterns in acute patients. J Cardiovasc Med (Hagerstown) 7:322–327CrossRef Mangieri E, Tanzilli G, De Vincentis G, Barillà F, Remediani S, Acconcia MC, Comito C, Gaudio C, Scopinaro F, Puddu PE, Critelli G (2006) Slow coronary flow and stress myocardial perfusion imaging. Different patterns in acute patients. J Cardiovasc Med (Hagerstown) 7:322–327CrossRef
43.
go back to reference Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R, Kosar F, Cehreli S (2007) Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Angiology 58:401–407PubMedCrossRef Barutcu I, Sezgin AT, Sezgin N, Gullu H, Esen AM, Topal E, Ozdemir R, Kosar F, Cehreli S (2007) Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow. Angiology 58:401–407PubMedCrossRef
44.
go back to reference Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I (2009) Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 206:61–68PubMedCrossRef Hein TW, Singh U, Vasquez-Vivar J, Devaraj S, Kuo L, Jialal I (2009) Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis 206:61–68PubMedCrossRef
45.
go back to reference Devaraj S, Yun JM, Adamson G, Galvez J, Jialal I (2009) C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res 84:479–484PubMedCrossRef Devaraj S, Yun JM, Adamson G, Galvez J, Jialal I (2009) C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovasc Res 84:479–484PubMedCrossRef
Metadata
Title
Clinical analysis of the risk factors of slow coronary flow
Authors
Shuang Xia
Song-Bai Deng
Yang Wang
Jun Xiao
Jian-Lin Du
Yu Zhang
Xi-Chun Wang
Ye-Qing Li
Rui Zhao
Li He
Yu-Luan Xiang
Qiang She
Publication date
01-09-2011
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 5/2011
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-010-0081-5

Other articles of this Issue 5/2011

Heart and Vessels 5/2011 Go to the issue